WCM Investment Management
BMRN icon

WCM Investment Management’s BioMarin Pharmaceuticals BMRN Stock Holding History

WCM Investment Management’s Portfolio BMRN Stock Details BMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.03M Sell
18,830
-46
-0.2% -$2.68K ﹤0.01% 234
2025
Q4 		$1.11M Buy
18,876
+9,251
+96% +$504K ﹤0.01% 221
2025
Q3 		$520K Buy
9,625
+320
+3% +$18.3K ﹤0.01% 215
2025
Q2 		$513K Sell
9,305
-8,048
-46% -$474K ﹤0.01% 208
2025
Q1 		$1.24M Sell
17,353
-187
-1% -$12.6K ﹤0.01% 242
2024
Q4 		$1.15M Buy
17,540
+595
+4% +$39.9K ﹤0.01% 251
2024
Q3 		$1.2M Buy
16,945
+10,485
+162% +$876K ﹤0.01% 249
2024
Q2 		$539K Buy
6,460
+1,593
+33% +$133K ﹤0.01% 227
2024
Q1 		$425K Buy
4,867
+76
+2% +$6.8K ﹤0.01% 218
2023
Q4 		$465K Buy
+4,791
New +$424K ﹤0.01% 220

Other funds holding BMRN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return